Hepatocellular Carcinoma in the Setting of Metabolic Dysfunction Associated Steatotic Liver Disease
- 2 March 2026
- journal article
- review article
- Published by Springer Nature in Current Hepatology Reports
- Vol. 25 (1) , 5
Abstract
No abstract availableKeywords
Funding Information
- NCI (K08 CA237624)
- DOD PRCRP (W81XWH-20-1-0605)
This publication has 114 references indexed in Scilit:
- GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseJAMA Internal Medicine, 2024
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLDHepatology, 2020
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver DiseaseHepatology, 2019
- Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver DiseaseHepatology, 2019
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular CarcinomaJAMA Oncology, 2017
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective studyHepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hepatology, 2013
- the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic SteatohepatitisHepatology, 2010